Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with un…
Industry Peers
Biotechnology| Headline | Source | Time |
|---|---|---|
Yesterday | ||
Sana Biotechnology (SANA) Publishes 14 Month Diabetes Cell Therapy Results In NEJM Sana Biotechnology (NasdaqGS:SANA) reported long term follow up data from an investigator sponsored study of its HIP modified islet cell therapy for type 1 diabetes. Results published in The New England Journal of Medicine highlighted safety and durable islet cell function over 14 months without the use of immunosuppressive drugs. The transplanted cells were observed to survive, evade immune rejection, and maintain glucose regulating activity through the follow up period. Sana Biotechnology... | ||
This week | ||
Sana (SANA) Upgraded to Buy: Here's What You Should Know Sana (SANA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. | ||
Older | ||